Ipca Labs receives approval for voluntary closure of wholly owned subsidiary in Mexico
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2024-12-05 09:24 GMT | Update On 2024-12-05 09:24 GMT
Advertisement
Mumbai: Ipca Laboratories Limited has announced that the Company has received the necessary approval for the voluntary closure of its wholly owned subsidiary Ipca Pharmaceuticals Ltd SA de CV, Mexico. This wholly owned subsidiary incorporated in Mexico was not doing any business for the past several years.
"Voluntary closure of this wholly owned subsidiary will not have any impact on Company’s business or financials," the Company stated in a BSE filing.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.